Selected research
Industry Research
E-Cadherin ELISA Kit Industry Research Report 2026
Market perspective
The global E-Cadherin ELISA Kit market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for E-Cadherin ELISA Kit is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for E-Cadherin ELISA Kit is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for E-Cadherin ELISA Kit is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of E-Cadherin ELISA Kit include Wuhan Fine Biotech Co., Ltd., Shanghai Korain Biotech Co., Ltd., Thermo Fisher Scientific (China) Co., Ltd., Merck, Rockland Immunochemicals, Inc., OriGene Technologies, Inc., MyBiosource, Inc., Creative Biolabs and Boster Biological Technology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global E-Cadherin ELISA Kit market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
E-Cadherin ELISA Kit Market by Company
Wuhan Fine Biotech Co., Ltd.
Shanghai Korain Biotech Co., Ltd.
Thermo Fisher Scientific (China) Co., Ltd.
Merck
Rockland Immunochemicals, Inc.
OriGene Technologies, Inc.
MyBiosource, Inc.
Creative Biolabs
Boster Biological Technology
Bio-Techne
Assay Genie
Arigo Biolaboratories Corp.
Abcam
E-Cadherin ELISA Kit Segment by Type
Human
Mouse
Other
E-Cadherin ELISA Kit Segment by Application
Hospital
Research Institute
Other
E-Cadherin ELISA Kit Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global E-Cadherin ELISA Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of E-Cadherin ELISA Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of E-Cadherin ELISA Kit.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of E-Cadherin ELISA Kit manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of E-Cadherin ELISA Kit by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of E-Cadherin ELISA Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Human
- Mouse
- Other
Applications
- Hospital
- Research Institute
- Other
Companies covered
- Wuhan Fine Biotech Co., Ltd.
- Shanghai Korain Biotech Co., Ltd.
- Thermo Fisher Scientific (China) Co., Ltd.
- Merck
- Rockland Immunochemicals, Inc.
- OriGene Technologies, Inc.
- MyBiosource, Inc.
- Creative Biolabs
- Boster Biological Technology
- Bio-Techne
- Assay Genie
- Arigo Biolaboratories Corp.
- Abcam
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global E-Cadherin ELISA Kit Market Size (2021-2032)
- 2.2.2 Global E-Cadherin ELISA Kit Sales (2021-2032)
- 2.2.3 Global E-Cadherin ELISA Kit Market Average Price (2021-2032)
- 2.3 E-Cadherin ELISA Kit by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Human
- 2.3.3 Mouse
- 2.3.4 Other
- 2.4 E-Cadherin ELISA Kit by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Research Institute
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global E-Cadherin ELISA Kit Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global E-Cadherin ELISA Kit Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global E-Cadherin ELISA Kit Revenue of Manufacturers (2021-2026)
- 3.4 Global E-Cadherin ELISA Kit Average Price by Manufacturers (2021-2026)
- 3.5 Global E-Cadherin ELISA Kit Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of E-Cadherin ELISA Kit, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of E-Cadherin ELISA Kit, Product Type & Application
- 3.8 Global Manufacturers of E-Cadherin ELISA Kit, Established Date
- 3.9 Global E-Cadherin ELISA Kit Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Wuhan Fine Biotech Co., Ltd.
- 4.1.1 Wuhan Fine Biotech Co., Ltd. Company Information
- 4.1.2 Wuhan Fine Biotech Co., Ltd. Business Overview
- 4.1.3 Wuhan Fine Biotech Co., Ltd. E-Cadherin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Wuhan Fine Biotech Co., Ltd. E-Cadherin ELISA Kit Product Portfolio
- 4.1.5 Wuhan Fine Biotech Co., Ltd. Recent Developments
- 4.2 Shanghai Korain Biotech Co., Ltd.
- 4.2.1 Shanghai Korain Biotech Co., Ltd. Company Information
- 4.2.2 Shanghai Korain Biotech Co., Ltd. Business Overview
- 4.2.3 Shanghai Korain Biotech Co., Ltd. E-Cadherin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shanghai Korain Biotech Co., Ltd. E-Cadherin ELISA Kit Product Portfolio
- 4.2.5 Shanghai Korain Biotech Co., Ltd. Recent Developments
- 4.3 Thermo Fisher Scientific (China) Co., Ltd.
- 4.3.1 Thermo Fisher Scientific (China) Co., Ltd. Company Information
- 4.3.2 Thermo Fisher Scientific (China) Co., Ltd. Business Overview
- 4.3.3 Thermo Fisher Scientific (China) Co., Ltd. E-Cadherin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Thermo Fisher Scientific (China) Co., Ltd. E-Cadherin ELISA Kit Product Portfolio
- 4.3.5 Thermo Fisher Scientific (China) Co., Ltd. Recent Developments
- 4.4 Merck
- 4.4.1 Merck Company Information
- 4.4.2 Merck Business Overview
- 4.4.3 Merck E-Cadherin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merck E-Cadherin ELISA Kit Product Portfolio
- 4.4.5 Merck Recent Developments
- 4.5 Rockland Immunochemicals, Inc.
- 4.5.1 Rockland Immunochemicals, Inc. Company Information
- 4.5.2 Rockland Immunochemicals, Inc. Business Overview
- 4.5.3 Rockland Immunochemicals, Inc. E-Cadherin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Rockland Immunochemicals, Inc. E-Cadherin ELISA Kit Product Portfolio
- 4.5.5 Rockland Immunochemicals, Inc. Recent Developments
- 4.6 OriGene Technologies, Inc.
- 4.6.1 OriGene Technologies, Inc. Company Information
- 4.6.2 OriGene Technologies, Inc. Business Overview
- 4.6.3 OriGene Technologies, Inc. E-Cadherin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 OriGene Technologies, Inc. E-Cadherin ELISA Kit Product Portfolio
- 4.6.5 OriGene Technologies, Inc. Recent Developments
- 4.7 MyBiosource, Inc.
- 4.7.1 MyBiosource, Inc. Company Information
- 4.7.2 MyBiosource, Inc. Business Overview
- 4.7.3 MyBiosource, Inc. E-Cadherin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 MyBiosource, Inc. E-Cadherin ELISA Kit Product Portfolio
- 4.7.5 MyBiosource, Inc. Recent Developments
- 4.8 Creative Biolabs
- 4.8.1 Creative Biolabs Company Information
- 4.8.2 Creative Biolabs Business Overview
- 4.8.3 Creative Biolabs E-Cadherin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Creative Biolabs E-Cadherin ELISA Kit Product Portfolio
- 4.8.5 Creative Biolabs Recent Developments
- 4.9 Boster Biological Technology
- 4.9.1 Boster Biological Technology Company Information
- 4.9.2 Boster Biological Technology Business Overview
- 4.9.3 Boster Biological Technology E-Cadherin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Boster Biological Technology E-Cadherin ELISA Kit Product Portfolio
- 4.9.5 Boster Biological Technology Recent Developments
- 4.10 Bio-Techne
- 4.10.1 Bio-Techne Company Information
- 4.10.2 Bio-Techne Business Overview
- 4.10.3 Bio-Techne E-Cadherin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Bio-Techne E-Cadherin ELISA Kit Product Portfolio
- 4.10.5 Bio-Techne Recent Developments
- 4.11 Assay Genie
- 4.11.1 Assay Genie Company Information
- 4.11.2 Assay Genie Business Overview
- 4.11.3 Assay Genie E-Cadherin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Assay Genie E-Cadherin ELISA Kit Product Portfolio
- 4.11.5 Assay Genie Recent Developments
- 4.12 Arigo Biolaboratories Corp.
- 4.12.1 Arigo Biolaboratories Corp. Company Information
- 4.12.2 Arigo Biolaboratories Corp. Business Overview
- 4.12.3 Arigo Biolaboratories Corp. E-Cadherin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Arigo Biolaboratories Corp. E-Cadherin ELISA Kit Product Portfolio
- 4.12.5 Arigo Biolaboratories Corp. Recent Developments
- 4.13 Abcam
- 4.13.1 Abcam Company Information
- 4.13.2 Abcam Business Overview
- 4.13.3 Abcam E-Cadherin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Abcam E-Cadherin ELISA Kit Product Portfolio
- 4.13.5 Abcam Recent Developments
5 Global E-Cadherin ELISA Kit Market Scenario by Region
- 5.1 Global E-Cadherin ELISA Kit Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global E-Cadherin ELISA Kit Sales by Region: 2021-2032
- 5.2.1 Global E-Cadherin ELISA Kit Sales by Region: 2021-2026
- 5.2.2 Global E-Cadherin ELISA Kit Sales by Region: 2027-2032
- 5.3 Global E-Cadherin ELISA Kit Revenue by Region: 2021-2032
- 5.3.1 Global E-Cadherin ELISA Kit Revenue by Region: 2021-2026
- 5.3.2 Global E-Cadherin ELISA Kit Revenue by Region: 2027-2032
- 5.4 North America E-Cadherin ELISA Kit Market Facts & Figures by Country
- 5.4.1 North America E-Cadherin ELISA Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America E-Cadherin ELISA Kit Sales by Country (2021-2032)
- 5.4.3 North America E-Cadherin ELISA Kit Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe E-Cadherin ELISA Kit Market Facts & Figures by Country
- 5.5.1 Europe E-Cadherin ELISA Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe E-Cadherin ELISA Kit Sales by Country (2021-2032)
- 5.5.3 Europe E-Cadherin ELISA Kit Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific E-Cadherin ELISA Kit Market Facts & Figures by Country
- 5.6.1 Asia Pacific E-Cadherin ELISA Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific E-Cadherin ELISA Kit Sales by Country (2021-2032)
- 5.6.3 Asia Pacific E-Cadherin ELISA Kit Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America E-Cadherin ELISA Kit Market Facts & Figures by Country
- 5.7.1 South America E-Cadherin ELISA Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America E-Cadherin ELISA Kit Sales by Country (2021-2032)
- 5.7.3 South America E-Cadherin ELISA Kit Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa E-Cadherin ELISA Kit Market Facts & Figures by Country
- 5.8.1 Middle East and Africa E-Cadherin ELISA Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa E-Cadherin ELISA Kit Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa E-Cadherin ELISA Kit Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global E-Cadherin ELISA Kit Sales by Type (2021-2032)
- 6.1.1 Global E-Cadherin ELISA Kit Sales by Type (2021-2032) & (k units)
- 6.1.2 Global E-Cadherin ELISA Kit Sales Market Share by Type (2021-2032)
- 6.2 Global E-Cadherin ELISA Kit Revenue by Type (2021-2032)
- 6.2.1 Global E-Cadherin ELISA Kit Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global E-Cadherin ELISA Kit Revenue Market Share by Type (2021-2032)
- 6.3 Global E-Cadherin ELISA Kit Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global E-Cadherin ELISA Kit Sales by Application (2021-2032)
- 7.1.1 Global E-Cadherin ELISA Kit Sales by Application (2021-2032) & (k units)
- 7.1.2 Global E-Cadherin ELISA Kit Sales Market Share by Application (2021-2032)
- 7.2 Global E-Cadherin ELISA Kit Revenue by Application (2021-2032)
- 7.2.1 Global E-Cadherin ELISA Kit Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global E-Cadherin ELISA Kit Revenue Market Share by Application (2021-2032)
- 7.3 Global E-Cadherin ELISA Kit Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 E-Cadherin ELISA Kit Value Chain Analysis
- 8.1.1 E-Cadherin ELISA Kit Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 E-Cadherin ELISA Kit Production Mode & Process
- 8.2 E-Cadherin ELISA Kit Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 E-Cadherin ELISA Kit Distributors
- 8.2.3 E-Cadherin ELISA Kit Customers
9 Global E-Cadherin ELISA Kit Analyzing Market Dynamics
- 9.1 E-Cadherin ELISA Kit Industry Trends
- 9.2 E-Cadherin ELISA Kit Industry Drivers
- 9.3 E-Cadherin ELISA Kit Industry Opportunities and Challenges
- 9.4 E-Cadherin ELISA Kit Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst